Topical Scar Treatment Market in China, South Korea, Taiwan, Hong Kong, and Southeast Asia – Revenue Estimation and Forecast by 2030

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Analysis Period

1.4 Market Data Reporting Unit

1.4.1 Volume

1.4.2 Value

1.5 Market Size Breakdown by Segment

1.5.1 Market Segmentation by Product Type

1.5.2 Market Segmentation by Scar Type

1.5.3 Market Segmentation by Distribution Channel

1.5.4 Market Segment Analysis of Countries

1.6 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.1.1 Paid

2.1.2 Unpaid

2.1.3 P&S Intelligence Database

2.2 Primary Research

2.2.1 Breakdown of Primary Research, by Industry Participant

2.2.2 Breakdown of Primary Research, by Designation

2.2.3 Breakdown of Primary Research, by Company Type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Currency Conversion Rates

2.6 Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Product Type

4.1.1.1 Cream

4.1.1.2 Oil

4.1.1.3 Gel

4.1.1.4 Gel sheet

4.1.1.5 Others

4.1.2 By Scar Type

4.1.2.1 Atrophic and acne scar

4.1.2.2 Keloid and hypertrophic scar

4.1.2.3 Contracture scar

4.1.2.4 Stretch mark

4.1.3 By Distribution Channel

4.1.3.1 Pharmacies

4.1.3.2 E-commerce

4.1.3.3 Direct sales

4.1.3.4 Grocery stores

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing demand for silicone-based scar treatment products

4.2.2 Drivers

4.2.2.1 Rising incidence of burns

4.2.2.2 Rising number of road accidents

4.2.2.3 Increasing cases of skin diseases

4.2.2.4 Growing aging population

4.2.2.5 Rising disposable income

4.2.2.6 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Side-effects of topical scar treatment products

4.2.3.2 Rising preference for technologically advanced treatments

4.2.3.3 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Adoption of e-commerce for branding and marketing

4.3 COVID-19 Impact

4.4 Porter’s Five Forces Analysis

4.4.1 Bargaining Power of Buyers

4.4.2 Bargaining Power of Suppliers

4.4.3 Intensity of Rivalry

4.4.4 Threat of New Entrants

4.4.5 Threat of Substitutes

Chapter 5. China, South Korea, Taiwan, Hong Kong and SEA Market Size and Forecast

5.1 Overview

5.2 Market Revenue, by Product Type (2025–2030)

5.3 Market Revenue, by Scar Type (2025–2030)

5.4 Market Revenue, by Distribution Channel (2025–2030)

5.5 Market Revenue, by Country (2025–2030)

Chapter 6. China Market Size and Forecast

6.1 Overview

6.2 Market Revenue, by Product Type (2025–2030)

6.3 Market Revenue, by Scar Type (2025–2030)

6.4 Market Revenue, by Distribution Channel (2025–2030)

Chapter 7. Indonesia Market Size and Forecast

7.1 Overview

7.2 Market Revenue, by Product Type (2025–2030)

7.3 Market Revenue, by Scar Type (2025–2030)

7.4 Market Revenue, by Distribution Channel (2025–2030)

Chapter 8. Philippines Market Size and Forecast

8.1 Overview

8.2 Market Revenue, by Product Type (2025–2030)

8.3 Market Revenue, by Scar Type (2025–2030)

8.4 Market Revenue, by Distribution Channel (2025–2030)

Chapter 9. Vietnam Market Size and Forecast

9.1 Overview

9.2 Market Revenue, by Product Type (2025–2030)

9.3 Market Revenue, by Scar Type (2025–2030)

9.4 Market Revenue, by Distribution Channel (2025–2030)

Chapter 10. Thailand Market Size and Forecast

10.1 Overview

10.2 Market Revenue, by Product Type (2025–2030)

10.3 Market Revenue, by Scar Type (2025–2030)

10.4 Market Revenue, by Distribution Channel (2025–2030)

Chapter 11. South Korea Market Size and Forecast

11.1 Overview

11.2 Market Revenue, by Product Type (2025–2030)

11.3 Market Revenue, by Scar Type (2025–2030)

11.4 Market Revenue, by Distribution Channel (2025–2030)

Chapter 12. Malaysia Market Size and Forecast

12.1 Overview

12.2 Market Revenue, by Product Type (2025–2030)

12.3 Market Revenue, by Scar Type (2025–2030)

12.4 Market Revenue, by Distribution Channel (2025–2030)

Chapter 13. Taiwan Market Size and Forecast

13.1 Overview

13.2 Market Revenue, by Product Type (2025–2030)

13.3 Market Revenue, by Scar Type (2025–2030)

13.4 Market Revenue, by Distribution Channel (2025–2030)

Chapter 14. Hong Kong Market Size and Forecast

14.1 Overview

14.2 Market Revenue, by Product Type (2025–2030)

14.3 Market Revenue, by Scar Type (2025–2030)

14.4 Market Revenue, by Distribution Channel (2025–2030)

Chapter 15. Competitive Landscape

15.1 China

15.1.1 Brand Share Analysis, by Product Type

15.1.1.1 Cream

15.1.1.2 Gel

15.1.1.3 Oil

15.1.1.4 Gel sheet

15.2 Indonesia

15.2.1 Brand Share Analysis, by Product Type

15.2.1.1 Cream

15.2.1.2 Gel

15.2.1.3 Oil

15.2.1.4 Gel sheet

15.3 Philippines

15.3.1 Brand Share Analysis, by Product Type

15.3.1.1 Cream

15.3.1.2 Gel

15.3.1.3 Oil

15.3.1.4 Gel sheet

15.4 Vietnam

15.4.1 Brand Share Analysis, by Product Type

15.4.1.1 Cream

15.4.1.2 Gel

15.4.1.3 Oil

15.4.1.4 Gel sheet

15.5 Thailand

15.5.1 Brand Share Analysis, by Product Type

15.5.1.1 Cream

15.5.1.2 Gel

15.5.1.3 Oil

15.5.1.4 Gel sheet

15.6 South Korea

15.6.1 Brand Share Analysis, by Product Type

15.6.1.1 Cream

15.6.1.2 Gel

15.6.1.3 Oil

15.6.1.4 Gel sheet

15.7 Malaysia

15.7.1 Brand Share Analysis, by Product Type

15.7.1.1 Cream

15.7.1.2 Gel

15.7.1.3 Oil

15.7.1.4 Gel sheet

15.8 Taiwan

15.8.1 Brand Share Analysis, by Product Type

15.8.1.1 Cream

15.8.1.2 Gel

15.8.1.3 Oil

15.8.1.4 Gel sheet

15.9 Hong Kong

15.9.1 Brand Share Analysis, by Product Type

15.9.1.1 Cream

15.9.1.2 Gel

15.9.1.3 Oil

15.9.1.4 Gel sheet

15.10 Recent Strategic Developments

15.10.1 Product Launches and Approvals

15.10.2 Acquisitions and Mergers

15.10.3 Other Developments

Chapter 16. Company Profiles

16.1 Perrigo Company plc

16.1.1 Business Overview

16.1.2 Product and Service Offerings

16.1.3 Key Financial Summary

16.2 Laboratoire HRA Pharma SAS

16.2.1 Business Overview

16.2.2 Product and Service Offerings

16.3 Cicatricure (Genomma Lab USA Inc.)

16.3.1 Business Overview

16.3.2 Product and Service Offerings

16.4 Terez & Honor

16.4.1 Business Overview

16.4.2 Product and Service Offerings

16.5 Sientra Inc.

16.5.1 Business Overview

16.5.2 Product and Service Offerings

16.5.3 Key Financial Summary

16.6 Aroamas LLC (EHY HOLDINGS LLC)

16.6.1 Business Overview

16.6.2 Product and Service Offerings

16.7 Integra LifeSciences Holdings Corporation

16.7.1 Business Overview

16.7.2 Product and Service Offerings

16.7.3 Key Financial Summary

16.8 Johnson & Johnson

16.8.1 Business Overview

16.8.2 Product and Service Offerings

16.8.3 Key Financial Summary

16.9 Revitol Corporation

16.9.1 Business Overview

16.9.2 Product and Service Offerings

16.10 Sonoma Pharmaceuticals Inc.

16.10.1 Business Overview

16.10.2 Product and Service Offerings

16.10.3 Key Financial Summary

16.11 Smith & Nephew PLC

16.11.1 Business Overview

16.11.2 Product and Service Offerings

16.11.3 Key Financial Summary

16.12 Mölnlycke Health Care AB

16.12.1 Business Overview

16.12.2 Product and Service Offerings

16.12.3 Key Financial Summary

16.13 Mylan N.V.

16.13.1 Business Overview

16.13.2 Product and Service Offerings

16.13.3 Key Financial Summary

16.14 Merz Pharma GmbH & Co. KGaA

16.14.1 Business Overview

16.14.2 Product and Service Offerings

16.15 Alliance Pharma plc

16.16.1 Business Overview

16.16.2 Product and Service Offerings

16.16.5 Key Financial Summary

Chapter 17. Appendix

17.1 Abbreviations

17.2 Sources and References

17.3 Related Reports

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2019–2024)

TABLE 5 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 6 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 7 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2019–2024)

TABLE 8 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 9 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 10 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2019–2024)

TABLE 11 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 12 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 13 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY COUNTRY, $M (2019–2024)

TABLE 14 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY COUNTRY, $M (2025–2030)

TABLE 15 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY COUNTRY, $M (2025–2030)

TABLE 16 CHINA TOPICAL SCAR TREATMENT MARKET VOLUME, BY PRODUCT TYPE, THOUSAND UNITS (2023)

TABLE 17 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2019–2024)

TABLE 18 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 19 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 20 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2019–2024)

TABLE 21 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 22 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 23 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2019–2024)

TABLE 24 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 25 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 26 INDONESIA TOPICAL SCAR TREATMENT MARKET VOLUME, BY PRODUCT TYPE, THOUSAND UNITS (2023)

TABLE 27 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2019–2024)

TABLE 28 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 29 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 30 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2019–2024)

TABLE 31 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 32 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 33 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2019–2024)

TABLE 34 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 35 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 36 PHILIPPINES TOPICAL SCAR TREATMENT MARKET VOLUME, BY PRODUCT TYPE, THOUSAND UNITS (2023)

TABLE 37 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2019–2024)

TABLE 38 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 39 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 40 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2019–2024)

TABLE 41 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 42 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 43 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2019–2024)

TABLE 44 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 45 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 46 VIETNAM TOPICAL SCAR TREATMENT MARKET VOLUME, BY PRODUCT TYPE, THOUSAND UNITS (2023)

TABLE 47 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2019–2024)

TABLE 48 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 49 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 50 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2019–2024)

TABLE 51 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 52 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 53 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2019–2024)

TABLE 54 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 55 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 56 THAILAND TOPICAL SCAR TREATMENT MARKET VOLUME, BY PRODUCT TYPE, THOUSAND UNITS (2023)

TABLE 57 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2019–2024)

TABLE 58 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 59 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 60 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2019–2024)

TABLE 61 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 62 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 63 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2019–2024)

TABLE 64 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 65 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 66 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET VOLUME, BY PRODUCT TYPE, THOUSAND UNITS (2023)

TABLE 67 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2019–2024)

TABLE 68 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 69 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 70 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2019–2024)

TABLE 71 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 72 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 73 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2019–2024)

TABLE 74 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 75 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 76 MALAYSIA TOPICAL SCAR TREATMENT MARKET VOLUME, BY PRODUCT TYPE, THOUSAND UNITS (2023)

TABLE 77 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2019–2024)

TABLE 78 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 79 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 80 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2019–2024)

TABLE 81 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 82 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 83 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2019–2024)

TABLE 84 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 85 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 86 TAIWAN TOPICAL SCAR TREATMENT MARKET VOLUME, BY PRODUCT TYPE, THOUSAND UNITS (2023)

TABLE 87 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2019–2024)

TABLE 88 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 89 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 90 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2019–2024)

TABLE 91 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 92 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 93 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2019–2024)

TABLE 94 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 95 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 96 HONG KONG TOPICAL SCAR TREATMENT MARKET VOLUME, BY PRODUCT TYPE, THOUSAND UNITS (2023)

TABLE 97 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2019–2024)

TABLE 98 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 99 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

TABLE 100 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2019–2024)

TABLE 101 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 102 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

TABLE 103 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2019–2024)

TABLE 104 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 105 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

TABLE 106 BRAND SHARE ANALYSIS OF CREAMS (2023)

TABLE 107 BRAND SHARE ANALYSIS OF GEL (2023)

TABLE 108 BRAND SHARE ANALYSIS OF OIL (2023)

TABLE 109 BRAND SHARE ANALYSIS OF GEL SHEETS (2023)

TABLE 110 BRAND SHARE ANALYSIS OF CREAMS (2023)

TABLE 111 BRAND SHARE ANALYSIS OF GEL (2023)

TABLE 112 BRAND SHARE ANALYSIS OF OIL (2023)

TABLE 113 BRAND SHARE ANALYSIS OF GEL SHEETS (2023)

TABLE 114 BRAND SHARE ANALYSIS OF CREAMS (2023)

TABLE 115 BRAND SHARE ANALYSIS OF GEL (2023)

TABLE 116 BRAND SHARE ANALYSIS OF OIL (2023)

TABLE 117 BRAND SHARE ANALYSIS OF GEL SHEETS (2023)

TABLE 118 BRAND SHARE ANALYSIS OF CREAMS (2023)

TABLE 119 BRAND SHARE ANALYSIS OF GEL (2023)

TABLE 120 BRAND SHARE ANALYSIS OF OIL (2023)

TABLE 121 BRAND SHARE ANALYSIS OF GEL SHEETS (2023)

TABLE 122 BRAND SHARE ANALYSIS OF CREAMS (2023)

TABLE 123 BRAND SHARE ANALYSIS OF GEL (2023)

TABLE 124 BRAND SHARE ANALYSIS OF OIL (2023)

TABLE 125 BRAND SHARE ANALYSIS OF GEL SHEETS (2023)

TABLE 126 BRAND SHARE ANALYSIS OF CREAMS (2023)

TABLE 127 BRAND SHARE ANALYSIS OF GEL (2023)

TABLE 128 BRAND SHARE ANALYSIS OF OIL (2023)

TABLE 129 BRAND SHARE ANALYSIS OF GEL SHEETS (2023)

TABLE 130 BRAND SHARE ANALYSIS OF CREAMS (2023)

TABLE 131 BRAND SHARE ANALYSIS OF GEL (2023)

TABLE 132 BRAND SHARE ANALYSIS OF OIL (2023)

TABLE 133 BRAND SHARE ANALYSIS OF GEL SHEETS (2023)

TABLE 134 BRAND SHARE ANALYSIS OF CREAMS (2023)

TABLE 135 BRAND SHARE ANALYSIS OF GEL (2023)

TABLE 136 BRAND SHARE ANALYSIS OF OIL (2023)

TABLE 137 BRAND SHARE ANALYSIS OF GEL SHEETS (2023)

TABLE 138 BRAND SHARE ANALYSIS OF CREAMS (2023)

TABLE 139 BRAND SHARE ANALYSIS OF GEL (2023)

TABLE 140 BRAND SHARE ANALYSIS OF OIL (2023)

TABLE 141 BRAND SHARE ANALYSIS OF GEL SHEETS (2023)

TABLE 142 PERRIGO COMPANY PLC – AT A GLANCE

TABLE 143 PERRIGO COMPANY PLC – KEY FINANCIAL SUMMARY

TABLE 144 LABORATOIRE HRA PHARMA SAS – AT A GLANCE

TABLE 145 CICATRICURE (GENOMMA LAB USA INC.) – AT A GLANCE

TABLE 146 TEREZ & HONOR – AT A GLANCE

TABLE 147 SIENTRA INC. – AT A GLANCE

TABLE 148 SIENTRA INC. – KEY FINANCIAL SUMMARY

TABLE 149 AROAMAS LLC (EHY HOLDINGS LLC) – AT A GLANCE

TABLE 150 INTEGRA LIFESCIENCES HOLDINGS CORPORATION – AT A GLANCE

TABLE 151 INTEGRA LIFESCIENCES HOLDINGS CORPORATION – KEY FINANCIAL SUMMARY

TABLE 152 JOHNSON & JOHNSON – AT A GLANCE

TABLE 153 JOHNSON & JOHNSON – KEY FINANCIAL SUMMARY

TABLE 154 REVITOL CORPORATION – AT A GLANCE

TABLE 155 SONOMA PHARMACEUTICALS INC. – AT A GLANCE

TABLE 156 SONOMA PHARMACEUTICALS INC. – KEY FINANCIAL SUMMARY

TABLE 157 SMITH & NEPHEW PLC – AT A GLANCE

TABLE 158 SMITH & NEPHEW PLC – KEY FINANCIAL SUMMARY

TABLE 159 MÖLNLYCKE HEALTH CARE AB – AT A GLANCE

TABLE 160 MÖLNLYCKE HEALTH CARE AB – KEY FINANCIAL SUMMARY

TABLE 161 MYLAN N.V. – AT A GLANCE

TABLE 162 MYLAN N.V. – KEY FINANCIAL SUMMARY

TABLE 163 MERZ PHARMA GMBH & CO. KGAA – AT A GLANCE

TABLE 164 ALLIANCE PHARMA PLC – AT A GLANCE

TABLE 165 ALLIANCE PHARMA PLC – KEY FINANCIAL SUMMARY

 

LIST OF FIGURES

 

FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT

FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 CURRENCY CONVERSION RATES FOR USD (2023)

FIG 8 TOPICAL SCAR TREATMENT MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 INTENSITY OF RIVALRY

FIG 12 THREAT OF NEW ENTRANTS

FIG 13 THREAT OF SUBSTITUTES

FIG 14 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET SNAPSHOT

FIG 15 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

FIG 16 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

FIG 17 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

FIG 18 CHINA, SOUTH KOREA, TAIWAN, HONG KONG AND SEA TOPICAL SCAR TREATMENT MARKET REVENUE, BY COUNTRY, $M (2025–2030)

FIG 19 CHINA TOPICAL SCAR TREATMENT MARKET SNAPSHOT

FIG 20 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

FIG 21 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

FIG 22 CHINA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

FIG 23 INDONESIA TOPICAL SCAR TREATMENT MARKET SNAPSHOT

FIG 24 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

FIG 25 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

FIG 26 INDONESIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

FIG 27 PHILIPPINES TOPICAL SCAR TREATMENT MARKET SNAPSHOT

FIG 28 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

FIG 29 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

FIG 30 PHILIPPINES TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

FIG 31 VIETNAM TOPICAL SCAR TREATMENT MARKET SNAPSHOT

FIG 32 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

FIG 33 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

FIG 34 VIETNAM TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

FIG 35 THAILAND TOPICAL SCAR TREATMENT MARKET SNAPSHOT

FIG 36 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

FIG 37 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

FIG 38 THAILAND TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

FIG 39 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET SNAPSHOT

FIG 40 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

FIG 41 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

FIG 42 SOUTH KOREA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

FIG 43 MALAYSIA TOPICAL SCAR TREATMENT MARKET SNAPSHOT

FIG 44 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

FIG 45 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

FIG 46 MALAYSIA TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

FIG 47 TAIWAN TOPICAL SCAR TREATMENT MARKET SNAPSHOT

FIG 48 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

FIG 49 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

FIG 50 TAIWAN TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

FIG 51 HONG KONG TOPICAL SCAR TREATMENT MARKET SNAPSHOT

FIG 52 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY PRODUCT TYPE, $M (2025–2030)

FIG 53 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY SCAR TYPE, $M (2025–2030)

FIG 54 HONG KONG TOPICAL SCAR TREATMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2025–2030)

FIG 55 PERRIGO COMPANY PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 56 SIENTRA INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 57 INTEGRA LIFESCIENCES HOLDINGS CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 58 JOHNSON & JOHNSON – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 59 SONOMA PHARMACEUTICALS INC. – REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2023)

FIG 60 SMITH & NEPHEW PLC – REVENUE SPLIT BY SEGMENTS AND GEOGRAPHY (2023)

FIG 61 MÖLNLYCKE HEALTH CARE AB – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 62 MYLAN N.V. – REVENUE SPLIT BY THERAPEUTIC AREA AND GEOGRAPHY (2023)

FIG 63 ALLIANCE PHARMA PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)